Suchergebnisse - "Farrugia, Albert"

PubPharm (7)

1

The safety of plasma-derived haemophilia factor concentrates - comments on "Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates" Nunes Valença I et al. (2021). Deep viral metagenomics in patients with haemophilia receiving plasma-derived coagulation factor concentrates. Haemophilia. https://doi.org/10.1111/hae.14382

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2021

von Farrugia, A.

CommentOn: Haemophilia. 2021 Sep;27(5):e645-e648. - PMID 34313362

2

Storage of cryoprecipitate : Role of blood storage

enthalten in: Transfusion | 2021

von Farrugia, A.

CommentOn: Transfusion. 2021 May;61(5):1578-1585. - PMID 33728705

3

The discovery of cryoprecipitate as a modality for hemophilia A : Augmenting the allocation of credit

enthalten in: Transfusion | 2021

von Farrugia, A. | Sibinga, C.

CommentOn: Transfusion. 2021 Jun;61(6):1676-1677. - PMID 33894065

4

The growing importance of achieving national self-sufficiency in immunoglobulin in Italy. The emergence of a national imperative

enthalten in: Blood transfusion = Trasfusione del sangue | 2019

von Farrugia, A. | Grazzini, G. | Quinti, I. | +3

5

Pharmacokinetic and safety considerations when switching from standard to extended half-life clotting factor concentrates in hemophilia

enthalten in: Expert review of hematology | 2019

von Morfini, M. | Farrugia, A.

6

Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII : a budget-impact analysis" by Messori et al

enthalten in: Blood transfusion = Trasfusione del sangue | 2019

von Farrugia, A. | Bansal, M.

CommentOn: Blood Transfus. 2018 Feb;16(2):215-220. - PMID 28686156

7

Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia

enthalten in: Blood transfusion = Trasfusione del sangue | 2018

von Farrugia, A. | Liumbruno, G. | Candura, F. | +2

1
[1]